Patients’ Perception of CVD Risk, Management in Cancer Shows a Lack of Awareness
Interviews show that awareness of and preferences on when, how much, and the method of providing information on CVD risk varies among patients with cancer.
Black Adults With Cancer Prefer In-Person Care, Citing Discomfort, Technology Issues With Virtual Visits
An interview study explored the challenges and preferences of Black adults with cancer regarding virtual healthcare visits.
PFS With Venetoclax No Better Than With Pomalidomide for t(11;14) MM
Venetoclax plus dexamethasone did not improve progression-free survival over pomalidomide plus dexamethasone in patients with t(11;14)-positive relapsed or refractory multiple myeloma in the phase 3 CANOVA trial.
Tislelizumab Deemed Potential First-Line Option for HCC
Tislelizumab may be a first-line treatment option for patients with unresectable hepatocellular carcinoma, according to researchers.
PLCOm2012 Models Have High Sensitivity for Lung Cancer
PLCOm2012 models have higher sensitivity than USPSTF criteria, with no difference by Indigenous classification.
Identifying Effective Physical Activity Interventions for AYA Cancer Survivors
This literature review identified physical activity interventions that are most likely to improve participation among adolescent and young adult cancer survivors.
Linvoseltamab Shows Promising Results in Relapsed/Refractory Multiple Myeloma
Researchers sought to determine whether linvoseltamab would improve responses in patients with relapsed/refractory multiple myeloma.
Bridging Therapy Shows Low Efficacy in Patients With Multiple Myeloma Receiving CAR-T Therapy
Researchers sought to determine whether bridging therapy in multiple myeloma would improve outcomes with CAR-T therapy.
Incidence of Alpelisib-Induced Hyperglycemia in Metastatic Breast Cancer Higher in Real World vs Clinical Trials
Researchers found the incidence of alpelisib-induced hyperglycemia suggests that optimizing glycemic control is needed prior to initiating treatment with alpelisib.
Shorter Courses of Radiotherapy Increasingly Used for Prostate Cancer
Recent drop seen in proportion of patients receiving conventional fractionation; increase seen in moderate hypofractionation and ultrahypofractionation.
- Loading...
